Pharmaceuticals, Biotechnology and Life Sciences
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present…
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biotechnology company discovering and developing selective small molecule medicines that drug traditionally inaccessible targets,…
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biotechnology company discovering and developing selective small molecule medicines that drug traditionally inaccessible targets,…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present…
VANCOUVER, British Columbia–(BUSINESS WIRE)–Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that management will present…
SAN DIEGO–(BUSINESS WIRE)–Vividion Therapeutics, Inc., a biotechnology company discovering and developing selective small molecule medicines that drug traditionally inaccessible targets,…
SEOUL, South Korea–(BUSINESS WIRE)–#Eupolio–LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification…
SEOUL, South Korea–(BUSINESS WIRE)–#Eupolio–LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification…
SEOUL, South Korea–(BUSINESS WIRE)–#Eupolio–LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification…
SEOUL, South Korea–(BUSINESS WIRE)–#Eupolio–LG Chem announced today that its Sabin-Inactivated Polio Vaccine (Sabin-IPV) Eupolio™ received World Health Organization (WHO) prequalification…